A Safety Study of ARRY-502 in Healthy Subjects.

Trial Profile

A Safety Study of ARRY-502 in Healthy Subjects.

Phase of Trial: Phase I

Latest Information Update: 30 Jan 2012

At a glance

  • Drugs ARRY 502 (Primary)
  • Indications Allergic asthma; Seasonal allergic rhinitis
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 30 Jan 2012 Results were published in a Array BioPharma media release.
    • 19 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 10 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top